NCT02142231

Brief Summary

Test anxiety is a well-known phenomenon in general population, but only few scientific advances have been made in order to fully understand and prevent this circumstance. The number of students which use neuro enhancement to improve their performance and to prevent test anxiety, is increasing. A US-survey estimated that almost 7% of students in US universities have used prescription stimulants against anxiety, and that on some campuses, up to 25% of students had used them in the past year. Acupuncture might act as an alternate. Several trials could demonstrate, that different forms of acupuncture could relieve symptoms of pre-exam anxiety syndrome significantly and that this therapy was highly safe. In special, the investigation of single point effects in test anxiety could be of general interest. The acupuncture point with the most convincing evidence up to date is Heart 7. Yet, its effectiveness has mainly been chosen in combination with other acupuncture points and not as single remedy in test anxiety. Therefore we establish a trial investigating the immediate needling effects at Heart 7 on the reduction of test anxiety. Therefore qe implemented a validated stress test, the Trier Social Stress Test TSST, which is known to provoke serious stress responses in healthy subjects. 24 medical students with test anxiety in there history will be randomised to two interventional groups (verum acupuncture and laser acupuncture), being treated and then pass this test. Main outcome is the increase of cortisol in saliva, which is the standardized measure of stress response used in this paradigm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2014

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 20, 2014

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

January 7, 2015

Status Verified

January 1, 2015

Enrollment Period

2 months

First QC Date

April 24, 2014

Last Update Submit

January 6, 2015

Conditions

Keywords

acupuncturetest anxietyneuroenhancerplacebo

Outcome Measures

Primary Outcomes (1)

  • Cortisol in saliva

    Saliva samples will be obtained at above mentioned intervals for subsequent analysis of cortisol a in saliva. The stress model used in this trial is supposed to elevate cortisol in saliva 3-5 fold in controls.

    8 timepoints (in minutes: -40;-10;+10;+20;+30;+40;+55;+70)

Secondary Outcomes (5)

  • Test Anxiety on a Visual Analogue Scale

    4 timepoints (in minutes: -40;-10;+20;+55)

  • Primary Appraisal Secondary Appraisal

    2 timepoints (-40 and +10 minutes)

  • Multidimensional Mood State Questionnaire

    4 timepoints )in minutes: -40;-10;+10;+20)

  • State Trait Anxiety Questionnaire

    3 timepoints (in minutes: -40;-10;+10)

  • alpha amylase in saliva

    6 timepoints (in minutes: -40;-10;+10;+20;+30;+55)

Study Arms (2)

Laser Acupuncture

PLACEBO COMPARATOR

Subjects and Therapists are blinded. Instead of a real Laser Acupuncture device (able to elicit physiologic responses) them is given a sham-laser device only radiating non-energetic red LED-light. Without palpation, therapists treat the acupoint Heart 7, on both wrists, each for 1 minute, with additional 18 minutes of resting time after.

Device: Laser Acupuncture

Acupuncture

ACTIVE COMPARATOR

Acupuncture at the acupoint Heart 7, on both wrists, each for 1 minute, eliciting a deqi-response, additional stimulation and total needle-in time of 20 minutes (2 minutes treatment and 18 minutes of resting time)

Device: Acupuncture

Interventions

Sterile Acupuncture Needles (Seirin (R) 0.15x0.2) will be used, Needles are inserted for approx. 0.5-1 cm until deqi response is elicited

Acupuncture

Therefore a laser irradiation is faked, approaching a nonfunctioning laser pen, which has been deactivated by the manufacturer (3B Scientific GmbH, Hamburg, Germany). Only red light is emitted. To further emphasize the imaginary power of this sham procedure, visual and acoustic signals accompany the red light emission. Patients are treated at the same acupuncture points as in the acupuncture group for one minute without skin contact. The resting time after treatment is 18 minutes.

Laser Acupuncture

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Test Anxiety in the clinical history
  • Male medical students 3rd to 5th year
  • Compliance
  • Age \> 18 years
  • Smoking cessation for 24 hours

You may not qualify if:

  • Severe physical or psychical illness
  • Psychiatric record in medical history
  • Continuous uptake of antipsychiatric medication, tranquilizers or neuro-enhancers
  • Acupuncture treatment within the last 4 weeks
  • Hang-over
  • Drug consumption
  • Smoking (\> 5 cigarettes/ day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical School, University of Regensburg

Germany, Bavaria, 93053, Germany

Location

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med.

Study Record Dates

First Submitted

April 24, 2014

First Posted

May 20, 2014

Study Start

April 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

January 7, 2015

Record last verified: 2015-01

Locations